The CEO of MDC reinforced that this breakthrough improves patient safety and comfort in addition to improving surgical outcomes. With the increasing recognition and acceptance of robotic-assisted ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

In this retrospective case-control study, we analyzed the post-operative safety of patients undergoing cystoscopy with ureteral stent placement for obstructing ureteral calculi who tested positive for ...

The FDA has approved the Minima stent system, the first device specifically designed for infants and young children with congenital heart defects. The innovative stent could help thousands of ...

Cipla and Alkem Laboratories have emerged as the leading contenders to acquire a controlling stake in Mumbai-based Sahajanand Medical Technologies (SMT), India’s largest cardiac stent manufacturer.

[2] Continued attention to the safety, efficacy and delivery of first-generation DES has led to the development of new antiproliferative agents, alongside alternative carrier systems and stent ...

Subsequently, an intravenous bolus of 5 ug/Kg of Tirofiban was given before the release of the stent, followed by a maintenance dose of 0.075 ug/Kg/min. Immediately subsequent to the procedure, 300 mg ...

Longer term studies and studies powered enough to look at the rare event of stent thrombosis will answer the question of long-term safety of DES. The factors implicated in late stent thrombosis ...

The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury ...